Global Cancer Diagnostics Service Market Research Report 2022

SKU ID : QYR-21946091 | Publishing Date : 02-Nov-2022 | No. of pages : 89

Detailed TOC of Global Cancer Diagnostics Service Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Breast Cancer
        1.2.3 Blood Cancer
        1.2.4 Lung Cancer
        1.2.5 Colorectal Cancer
        1.2.6 Ovarian Cancer
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Cancer Diagnostics Service Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Laboratories
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Diagnostics Service Market Perspective (2017-2028)
    2.2 Cancer Diagnostics Service Growth Trends by Region
        2.2.1 Cancer Diagnostics Service Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Diagnostics Service Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Diagnostics Service Market Dynamics
        2.3.1 Cancer Diagnostics Service Industry Trends
        2.3.2 Cancer Diagnostics Service Market Drivers
        2.3.3 Cancer Diagnostics Service Market Challenges
        2.3.4 Cancer Diagnostics Service Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Diagnostics Service Players by Revenue
        3.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2017-2022)
        3.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Diagnostics Service Revenue
    3.4 Global Cancer Diagnostics Service Market Concentration Ratio
        3.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2021
    3.5 Cancer Diagnostics Service Key Players Head office and Area Served
    3.6 Key Players Cancer Diagnostics Service Product Solution and Service
    3.7 Date of Enter into Cancer Diagnostics Service Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Diagnostics Service Breakdown Data by Type
    4.1 Global Cancer Diagnostics Service Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2023-2028)
5 Cancer Diagnostics Service Breakdown Data by Application
    5.1 Global Cancer Diagnostics Service Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Diagnostics Service Market Size (2017-2028)
    6.2 North America Cancer Diagnostics Service Market Size by Country (2017-2022)
    6.3 North America Cancer Diagnostics Service Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cancer Diagnostics Service Market Size (2017-2028)
    7.2 Europe Cancer Diagnostics Service Market Size by Country (2017-2022)
    7.3 Europe Cancer Diagnostics Service Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Diagnostics Service Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cancer Diagnostics Service Market Size (2017-2028)
    9.2 Latin America Cancer Diagnostics Service Market Size by Country (2017-2022)
    9.3 Latin America Cancer Diagnostics Service Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Diagnostics Service Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Illumina
        11.1.1 Illumina Company Detail
        11.1.2 Illumina Business Overview
        11.1.3 Illumina Cancer Diagnostics Service Introduction
        11.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.1.5 Illumina Recent Development
    11.2 BGI Genomics Co.,Ltd.
        11.2.1 BGI Genomics Co.,Ltd. Company Detail
        11.2.2 BGI Genomics Co.,Ltd. Business Overview
        11.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction
        11.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.2.5 BGI Genomics Co.,Ltd. Recent Development
    11.3 Agilent Technologies
        11.3.1 Agilent Technologies Company Detail
        11.3.2 Agilent Technologies Business Overview
        11.3.3 Agilent Technologies Cancer Diagnostics Service Introduction
        11.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.3.5 Agilent Technologies Recent Development
    11.4 Macrogen
        11.4.1 Macrogen Company Detail
        11.4.2 Macrogen Business Overview
        11.4.3 Macrogen Cancer Diagnostics Service Introduction
        11.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.4.5 Macrogen Recent Development
    11.5 Pacific Biosciences
        11.5.1 Pacific Biosciences Company Detail
        11.5.2 Pacific Biosciences Business Overview
        11.5.3 Pacific Biosciences Cancer Diagnostics Service Introduction
        11.5.4 Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.5.5 Pacific Biosciences Recent Development
    11.6 Abbott
        11.6.1 Abbott Company Detail
        11.6.2 Abbott Business Overview
        11.6.3 Abbott Cancer Diagnostics Service Introduction
        11.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.6.5 Abbott Recent Development
    11.7 QIAGEN
        11.7.1 QIAGEN Company Detail
        11.7.2 QIAGEN Business Overview
        11.7.3 QIAGEN Cancer Diagnostics Service Introduction
        11.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.7.5 QIAGEN Recent Development
    11.8 Siemens Healthcare GmbH
        11.8.1 Siemens Healthcare GmbH Company Detail
        11.8.2 Siemens Healthcare GmbH Business Overview
        11.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction
        11.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.8.5 Siemens Healthcare GmbH Recent Development
    11.9 Thermo Fisher Scientific, Inc.
        11.9.1 Thermo Fisher Scientific, Inc. Company Detail
        11.9.2 Thermo Fisher Scientific, Inc. Business Overview
        11.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction
        11.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.9.5 Thermo Fisher Scientific, Inc. Recent Development
    11.10 Applied DNA Sciences
        11.10.1 Applied DNA Sciences Company Detail
        11.10.2 Applied DNA Sciences Business Overview
        11.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction
        11.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2017-2022)
        11.10.5 Applied DNA Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Cancer Diagnostics Service Market Research Report 2022

List of Tables
    Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Breast Cancer
    Table 3. Key Players of Blood Cancer
    Table 4. Key Players of Lung Cancer
    Table 5. Key Players of Colorectal Cancer
    Table 6. Key Players of Ovarian Cancer
    Table 7. Key Players of Others
    Table 8. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Cancer Diagnostics Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Cancer Diagnostics Service Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Cancer Diagnostics Service Market Share by Region (2017-2022)
    Table 12. Global Cancer Diagnostics Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Cancer Diagnostics Service Market Share by Region (2023-2028)
    Table 14. Cancer Diagnostics Service Market Trends
    Table 15. Cancer Diagnostics Service Market Drivers
    Table 16. Cancer Diagnostics Service Market Challenges
    Table 17. Cancer Diagnostics Service Market Restraints
    Table 18. Global Cancer Diagnostics Service Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Cancer Diagnostics Service Market Share by Players (2017-2022)
    Table 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2021)
    Table 21. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Cancer Diagnostics Service Product Solution and Service
    Table 25. Date of Enter into Cancer Diagnostics Service Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Cancer Diagnostics Service Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Cancer Diagnostics Service Revenue Market Share by Type (2017-2022)
    Table 29. Global Cancer Diagnostics Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Cancer Diagnostics Service Revenue Market Share by Type (2023-2028)
    Table 31. Global Cancer Diagnostics Service Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Cancer Diagnostics Service Revenue Market Share by Application (2017-2022)
    Table 33. Global Cancer Diagnostics Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Cancer Diagnostics Service Revenue Market Share by Application (2023-2028)
    Table 35. North America Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Illumina Company Detail
    Table 46. Illumina Business Overview
    Table 47. Illumina Cancer Diagnostics Service Product
    Table 48. Illumina Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 49. Illumina Recent Development
    Table 50. BGI Genomics Co.,Ltd. Company Detail
    Table 51. BGI Genomics Co.,Ltd. Business Overview
    Table 52. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product
    Table 53. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 54. BGI Genomics Co.,Ltd. Recent Development
    Table 55. Agilent Technologies Company Detail
    Table 56. Agilent Technologies Business Overview
    Table 57. Agilent Technologies Cancer Diagnostics Service Product
    Table 58. Agilent Technologies Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 59. Agilent Technologies Recent Development
    Table 60. Macrogen Company Detail
    Table 61. Macrogen Business Overview
    Table 62. Macrogen Cancer Diagnostics Service Product
    Table 63. Macrogen Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 64. Macrogen Recent Development
    Table 65. Pacific Biosciences Company Detail
    Table 66. Pacific Biosciences Business Overview
    Table 67. Pacific Biosciences Cancer Diagnostics Service Product
    Table 68. Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 69. Pacific Biosciences Recent Development
    Table 70. Abbott Company Detail
    Table 71. Abbott Business Overview
    Table 72. Abbott Cancer Diagnostics Service Product
    Table 73. Abbott Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 74. Abbott Recent Development
    Table 75. QIAGEN Company Detail
    Table 76. QIAGEN Business Overview
    Table 77. QIAGEN Cancer Diagnostics Service Product
    Table 78. QIAGEN Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 79. QIAGEN Recent Development
    Table 80. Siemens Healthcare GmbH Company Detail
    Table 81. Siemens Healthcare GmbH Business Overview
    Table 82. Siemens Healthcare GmbH Cancer Diagnostics Service Product
    Table 83. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 84. Siemens Healthcare GmbH Recent Development
    Table 85. Thermo Fisher Scientific, Inc. Company Detail
    Table 86. Thermo Fisher Scientific, Inc. Business Overview
    Table 87. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product
    Table 88. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 89. Thermo Fisher Scientific, Inc. Recent Development
    Table 90. Applied DNA Sciences Company Detail
    Table 91. Applied DNA Sciences Business Overview
    Table 92. Applied DNA Sciences Cancer Diagnostics Service Product
    Table 93. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2017-2022) & (US$ Million)
    Table 94. Applied DNA Sciences Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Diagnostics Service Market Share by Type: 2021 VS 2028
    Figure 2. Breast Cancer Features
    Figure 3. Blood Cancer Features
    Figure 4. Lung Cancer Features
    Figure 5. Colorectal Cancer Features
    Figure 6. Ovarian Cancer Features
    Figure 7. Others Features
    Figure 8. Global Cancer Diagnostics Service Market Share by Application in 2021 & 2028
    Figure 9. Hospitals Case Studies
    Figure 10. Ambulatory Surgical Centers Case Studies
    Figure 11. Diagnostic Laboratories Case Studies
    Figure 12. Others Case Studies
    Figure 13. Cancer Diagnostics Service Report Years Considered
    Figure 14. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Cancer Diagnostics Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Cancer Diagnostics Service Market Share by Region: 2021 VS 2028
    Figure 17. Global Cancer Diagnostics Service Market Share by Players in 2021
    Figure 18. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2021
    Figure 20. North America Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Cancer Diagnostics Service Market Share by Country (2017-2028)
    Figure 22. United States Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Cancer Diagnostics Service Market Share by Country (2017-2028)
    Figure 26. Germany Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Cancer Diagnostics Service Market Share by Region (2017-2028)
    Figure 34. China Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Cancer Diagnostics Service Market Share by Country (2017-2028)
    Figure 42. Mexico Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2017-2028)
    Figure 46. Turkey Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Cancer Diagnostics Service Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 49. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 50. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 51. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 52. Pacific Biosciences Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 53. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 54. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 55. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 56. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 57. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed

Keyplayers in Global Cancer Diagnostics Service Market Research Report 2022

Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
Pacific Biosciences
Abbott
QIAGEN
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
Applied DNA Sciences